David P. Schenkein, Chief Executive Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 26,000 shares at $75.54 ($2.0M) on 2018-04-02, disclosed to the SEC on 2018-04-04.
Open-market sale of $2.0M AGIO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.54 | 1,557 | $118K | 5.8% |
| 2 | $75.54 | 1,557 | $118K | 5.8% |
| 3 | $76.40 | 2,600 | $199K | 9.8% |
| 4 | $76.40 | 2,600 | $199K | 9.8% |
| 5 | $77.76 | 3,340 | $260K | 12.9% |
| 6 | $77.76 | 3,340 |
| $260K |
| 12.9% |
| 7 | $78.59 | 3,390 | $266K | 13.2% |
| 8 | $78.59 | 3,390 | $266K | 13.2% |
| 9 | $79.49 | 2,113 | $168K | 8.3% |
| 10 | $79.49 | 2,113 | $168K | 8.3% |
| Total | $77.72 avg | 26,000 | $2.0M | 100% |
| Filing → |
| AGIO | SELL | 2024-02-27 | $4.5M | — | Filing → |
| AGIO | SELL | 2023-04-05 | $748K | — | Filing → |
| AGIO | SELL | 2023-03-29 | $443K | — | Filing → |